We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close
Focus On
Business | Labour & Employment | Wills,Trusts, & Estates | Family | Criminal | Civil Litigation | Personal Injury
NEW In-House Counsel | Insurance | Intellectual Property | Immigration | Natural Resources | Real Estate | Tax
Home > Intellectual Property

PATENTS - Criteria for patent protection - Non-obviousness - Inventive ingenuity - Procedure - Appeals

Thursday, May 04, 2017 @ 8:30 AM  

Appeal by Bristol-Myers Squibb from a ruling finding its 736 Patent invalid on the basis of obviousness. The appellant acquired rights to the atazanavir molecule, a complex molecule used to treat...

Focus On

Story image Cannabis: From mystery to medical intellectual property
Story image Budding this fall: The serious business of recreational cannabis
Story image Top judge suggests Ottawa should publicly explain when it rejects courts’ reasonable budget requests
Blaney McMurtry bolsters team with addition of eight associates
Experts’ opinion that Canada ‘caved on IP’ in USMCA is all about skewed perspective | May Cheng